# Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery

> **NCT06118957** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 64 (actual)

## Conditions studied

- Thromboembolism

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT06118957
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-11
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118957, "Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06118957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*